New treatment of urgency-frequency syndrome in female

Oxybutynin bladder instillation and nasal desmopressine (DDAVP)

F. Mantovani, E. Patelli, A. Ceresoli, M. Seveso

Research output: Contribution to journalArticle

Abstract

In painful bladder syndrome of phlogistic outcome, diagnostic assessment is able to distinguish between bacterial and non bacterial cystitis and endoscopy to evaluate the presence of leucoplasic trigonitis. In absence of infection or leucoplasia we propose the following management: bladder instillation (twice a week for a month) with oxybutynin 20 mg in 20 cc of saline solution. Desmopressine (0,2 cc by nasal drops) three hours before irrigation. On 12 patients all were cured at one year follow up even if 40% needed a second treatment. No side effects were described. Urine flow prevents effectiveness of direct administration of drugs in bladder. Oxybutynin is otherwise not long tolerated for well known side effects. The association with DDAVP (Desmopressine) makes the treatment reliable.

Original languageEnglish
Pages (from-to)53-56
Number of pages4
JournalUrogynaecologia International Journal
Volume10
Issue number2
Publication statusPublished - 1996

Fingerprint

Intravesical Administration
Deamino Arginine Vasopressin
Nose
Interstitial Cystitis
Cystitis
Sodium Chloride
Endoscopy
Outcome Assessment (Health Care)
Urine
Therapeutics
Infection
oxybutynin

Keywords

  • desmopressine (DDAVP)
  • oxybutynin
  • urgency-frequency syndrome

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

New treatment of urgency-frequency syndrome in female : Oxybutynin bladder instillation and nasal desmopressine (DDAVP). / Mantovani, F.; Patelli, E.; Ceresoli, A.; Seveso, M.

In: Urogynaecologia International Journal, Vol. 10, No. 2, 1996, p. 53-56.

Research output: Contribution to journalArticle

@article{6c2de2ac1c0c46bfbb47b1c62ca3c160,
title = "New treatment of urgency-frequency syndrome in female: Oxybutynin bladder instillation and nasal desmopressine (DDAVP)",
abstract = "In painful bladder syndrome of phlogistic outcome, diagnostic assessment is able to distinguish between bacterial and non bacterial cystitis and endoscopy to evaluate the presence of leucoplasic trigonitis. In absence of infection or leucoplasia we propose the following management: bladder instillation (twice a week for a month) with oxybutynin 20 mg in 20 cc of saline solution. Desmopressine (0,2 cc by nasal drops) three hours before irrigation. On 12 patients all were cured at one year follow up even if 40{\%} needed a second treatment. No side effects were described. Urine flow prevents effectiveness of direct administration of drugs in bladder. Oxybutynin is otherwise not long tolerated for well known side effects. The association with DDAVP (Desmopressine) makes the treatment reliable.",
keywords = "desmopressine (DDAVP), oxybutynin, urgency-frequency syndrome",
author = "F. Mantovani and E. Patelli and A. Ceresoli and M. Seveso",
year = "1996",
language = "English",
volume = "10",
pages = "53--56",
journal = "Urogynaecologia International Journal",
issn = "1121-3086",
publisher = "Associato All'USPI - Unione Stampa Periodica Italia",
number = "2",

}

TY - JOUR

T1 - New treatment of urgency-frequency syndrome in female

T2 - Oxybutynin bladder instillation and nasal desmopressine (DDAVP)

AU - Mantovani, F.

AU - Patelli, E.

AU - Ceresoli, A.

AU - Seveso, M.

PY - 1996

Y1 - 1996

N2 - In painful bladder syndrome of phlogistic outcome, diagnostic assessment is able to distinguish between bacterial and non bacterial cystitis and endoscopy to evaluate the presence of leucoplasic trigonitis. In absence of infection or leucoplasia we propose the following management: bladder instillation (twice a week for a month) with oxybutynin 20 mg in 20 cc of saline solution. Desmopressine (0,2 cc by nasal drops) three hours before irrigation. On 12 patients all were cured at one year follow up even if 40% needed a second treatment. No side effects were described. Urine flow prevents effectiveness of direct administration of drugs in bladder. Oxybutynin is otherwise not long tolerated for well known side effects. The association with DDAVP (Desmopressine) makes the treatment reliable.

AB - In painful bladder syndrome of phlogistic outcome, diagnostic assessment is able to distinguish between bacterial and non bacterial cystitis and endoscopy to evaluate the presence of leucoplasic trigonitis. In absence of infection or leucoplasia we propose the following management: bladder instillation (twice a week for a month) with oxybutynin 20 mg in 20 cc of saline solution. Desmopressine (0,2 cc by nasal drops) three hours before irrigation. On 12 patients all were cured at one year follow up even if 40% needed a second treatment. No side effects were described. Urine flow prevents effectiveness of direct administration of drugs in bladder. Oxybutynin is otherwise not long tolerated for well known side effects. The association with DDAVP (Desmopressine) makes the treatment reliable.

KW - desmopressine (DDAVP)

KW - oxybutynin

KW - urgency-frequency syndrome

UR - http://www.scopus.com/inward/record.url?scp=0029813811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029813811&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 53

EP - 56

JO - Urogynaecologia International Journal

JF - Urogynaecologia International Journal

SN - 1121-3086

IS - 2

ER -